Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Once Daily Administration Tadalafil in Patients With Benign Prostatic Hyperplasia

NCT06466369 is registered in ClinicalTrials.gov with Al-Azhar University as lead sponsor.

NCT NCT06466369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06466369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Once Daily Administration Tadalafil in Patients With Benign Prostatic Hyperplasia
Lead sponsor
Al-Azhar University
Phase
Phase 3
Overall status
Completed
Start date
March 15, 2024
Completion date
August 1, 2024
Enrollment
306 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bph with other lower urinary tract symptoms